NCT02638545View on ClinicalTrials.gov

Hemodynamic Effects of Dexmedetomidine in Septic Shock

PHASE3CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

February 28, 2017

Conditions
Septic Shock
Interventions
DRUG

Dexmedetomidine

Sedation with propofol and remifentanyl will be replaced by a sedation with dexmedetomidine and remifentanyl

Trial Locations (1)

00161

Departement of Anesthesiology and Intensive Care of the University of Rome La Sapienza, Rome

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT02638545 - Hemodynamic Effects of Dexmedetomidine in Septic Shock | Biotech Hunter | Biotech Hunter